Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Adults with a primary diagnosis of melanoma with involvement of lymph nodes or metastatic disease who have undergone complete surgical removal and have no evidence of disease
Decision to treat with adjuvant nivolumab therapy has already been taken
Ability to provide written informed consent to participate in the study
You may not be if
Adults with a current diagnosis of persisting advanced melanoma
Adults currently enrolled in an interventional clinical trial for his/her melanoma treatment
Clareo Health | An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Melanoma in Australia
